Enzymatic action of phospholipase A₂ on liposomal drug delivery systems
Anders H Hansen1, Ole G Mouritsen1, Ahmad Arouri1
1MEMPHYS-Center for Biomembrane Physics, Department of Physics, Chemistry, and Pharmacy, University of Southern Denmark, Odense, Denmark; The Lundbeck Foundation Nanomedicine Research Center for Cancer Stem Cell Targeting Therapeutics (NanoCAN), University of Southern Denmark, Odense, Denmark.
Abstract:
The overexpression of secretory phospholipase A2 (sPLA2) in tumors has opened new avenues for enzyme-triggered active unloading of liposomal antitumor drug carriers selectively at the target tumor. However, the effects of the liposome composition, drug encapsulation, and tumor microenvironment on the activity of sPLA2 are still not well understood. We carried out a physico-chemical study to characterize the sPLA2-assisted breakdown of liposomes using dye-release assays in the context of drug delivery and under physiologically relevant conditions. The influence of temperature, lipid concentration, enzyme concentration, and drug loading on the hydrolysis of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, Tm=42°C) liposomes with snake venom sPLA2 was investigated. The sensitivity of human sPLA2 to the liposome composition was checked using binary lipid mixtures of phosphatidylcholine (PC) and phosphatidylglycerol (PG) phospholipids with C14 and C16 acyl chains. Increasing temperature (36-41°C) was found to mainly shorten the enzyme lag-time, whereas the effect on lipid hydrolysis rate was modest. The enzyme lag-time was also found to be inversely dependent on the lipid-to-enzyme ratio. Drug encapsulation can alter the hydrolysis profile of the carrier liposomes. The activity of human sPLA2 was highly sensitive to the phospholipid acyl-chain length and negative surface charge density of the liposomes. We believe our work will prove useful for the optimization of sPLA2-susceptible liposomal formulations as well as will provide a solid ground for predicting the hydrolysis profile of the liposomes in vivo at the target site.
Insights
Secretory phospholipase A2 (sPLA2) enzyme activity on liposomes is sensitive to lipid composition and temperature, impacting drug delivery. Understanding these factors optimizes sPLA2-triggered liposomal drug release in tumors.
Area of Science:
- Biochemistry
- Materials Science
- Drug Delivery
Background:
- Overexpression of secretory phospholipase A2 (sPLA2) in tumors enables enzyme-triggered drug carrier unloading.
- Liposome composition, drug loading, and tumor microenvironment effects on sPLA2 activity require further investigation for targeted drug delivery.
Purpose of the Study:
- To physico-chemically characterize sPLA2-assisted liposome breakdown for drug delivery.
- To investigate the influence of temperature, lipid concentration, enzyme concentration, and drug loading on liposome hydrolysis.
- To assess sPLA2 sensitivity to liposome composition, including lipid acyl-chain length and surface charge.
Main Methods:
- Utilized dye-release assays to study liposome breakdown under physiologically relevant conditions.
- Investigated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) liposomes with snake venom sPLA2.
- Examined binary lipid mixtures of phosphatidylcholine (PC) and phosphatidylglycerol (PG) with varying acyl chains (C14, C16).
Main Results:
- Increased temperature (36-41°C) primarily reduced enzyme lag-time, with minor effects on lipid hydrolysis rate.
- Enzyme lag-time showed an inverse dependency on the lipid-to-enzyme ratio.
- Drug encapsulation altered liposome hydrolysis profiles.
- Human sPLA2 activity was highly sensitive to phospholipid acyl-chain length and liposome surface charge density.
Conclusions:
- Physico-chemical parameters significantly influence sPLA2-mediated liposome hydrolysis.
- Findings provide a basis for optimizing sPLA2-susceptible liposomal formulations for targeted cancer therapy.
- This research aids in predicting liposome hydrolysis in vivo for improved drug delivery efficacy.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Asymmetric Lipid Bilayer
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...


